Physiomics (LON:PYC) Trading 35.5% Higher – Should You Buy?

Shares of Physiomics Plc (LON:PYC) rose 35.5% on Tuesday . The company traded as high as GBX 1.10 ($0.01) and last traded at GBX 1.05 ($0.01). Approximately 20,006,418 shares were traded during trading, an increase of 186% from the average daily volume of 7,002,114 shares. The stock had previously closed at GBX 0.78 ($0.01).

Physiomics Price Performance

The firm has a 50 day moving average price of GBX 0.73 and a 200-day moving average price of GBX 0.71. The firm has a market cap of £1.71 million, a price-to-earnings ratio of -13.83 and a beta of 1.69.

Insider Activity

In related news, insider Peter Sargent bought 459,090 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were purchased at an average price of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,619.22). Insiders own 4.18% of the company’s stock.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.